Boston Scientific Corporation
BSX
•Stock Analysis$106.53
+0.00 (+0.00%)• Live
Boston Scientific Corporation Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Boston Scientific Corporation
Key Financial Metrics
for Boston Scientific Corporation
P/E Ratio
72.26
Revenue Growth
+17.61%
EPS Growth
+16.67%
Market Cap
$147.06B
Dividend Yield
0.00%
Debt/Equity
0.53
ROIC
+7.01%
FCF Yield
+1.95%
View additional metrics
Valuation
P/B Ratio6.61
EV/Sales9.00
Financial Health
Current Ratio1.45
Return on Assets+12.52%
Analyst Recommendations
for Boston Scientific Corporation
42 analysts
Consensus: Buy
About
for Boston Scientific Corporation
Company Details
for Boston Scientific Corporation
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael F. Mahoney
Employees
53,000
Market Cap
157.61B
Exchange
New York Stock Exchange
IPO Date
May 19, 1992
Website
www.bostonscientific.comCIK
0000885725
ISIN
US1011371077
CUSIP
101137107
Country
US
Balance Sheet
for Boston Scientific Corporation
Cash Flow Statement
for Boston Scientific Corporation
Income Statement
for Boston Scientific Corporation
News
No news available at the moment.